BICYCLE THERAPEUTICS PLC-ADR (BCYC) Stock Analyst Earnings Estimates
NASDAQ:BCYC - Nasdaq - US0887861088 - ADR - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 14.46M 23.59% | 26.976M 86.56% | 35.275M 30.76% | 31.862M -9.68% | 37.689M 18.29% | 110.77M 193.91% | 349.15M 215.20% | 662.24M 89.67% | 904.17M 36.53% | 1.274B 40.90% | 1.521B 19.39% | |
| EBITDA YoY % growth | -112.4M -74.07% | -182.806M -62.64% | -201.979M -10.49% | -264.62M -31.01% | -353.053M -33.42% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -116.09M -75.95% | -189.352M -63.11% | -209.153M -10.46% | -268.267M -28.26% | -320.481M -19.46% | -270.295M 15.66% | -104.57M 61.31% | 181.16M 273.24% | 420.23M 131.97% | 690.22M 64.25% | 885.69M 28.32% | |
| Operating Margin | -802.84% | -701.93% | -592.92% | -841.97% | -850.33% | -244.01% | -29.95% | 27.36% | 46.48% | 54.18% | 58.23% | |
| EPS YoY % growth | -3.80 -41.26% | -5.13 -35.00% | -2.95 42.50% | -3.63 -22.92% | -4.19 -15.46% | -3.64 13.09% | -1.78 51.13% | 1.30 172.85% | 3.79 192.91% | 6.38 68.01% | 7.24 13.60% |
All data in USD
| Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.87 -40.36% | -0.90 -16.61% | -0.95 -28.25% | -0.90 -9.79% | -1.00 -15.25% | -1.04 -15.50% | -1.08 -14.28% | -0.97 -7.64% |
| Revenue Q2Q % growth | 8.031M -58.88% | 7.287M -22.16% | 6.651M 148.54% | 7.035M 89.72% | 10.2M 27.01% | 10.2M 39.98% | 10.2M 53.36% | 10.2M 44.99% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -64.485M -102.87% | -66.737M -42.76% | -70.021M -10.22% | -71.528M -6.61% | -68.34M -5.98% | -71.4M -6.99% | -74.46M -6.34% | -76.5M -6.95% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | -0.82 29.31% | -0.88 | 0.06 | 6.37% |
| Q3 2024 Q2Q % growth | -0.74 41.27% | -0.80 | 0.06 | 7.19% |
| Q2 2024 Q2Q % growth | -0.77 45.39% | -1.12 | 0.35 | 31.27% |
| Q1 2024 Q2Q % growth | -0.62 52.31% | -1.27 | 0.65 | 51.12% |
| Q4 2023 Q2Q % growth | -1.16 -14.85% | -1.26 | 0.10 | 7.79% |
| Q3 2023 Q2Q % growth | -1.26 -31.25% | -1.19 | -0.07 | -5.45% |
| Q2 2023 Q2Q % growth | -1.41 -56.67% | -1.32 | -0.09 | -6.88% |
| Q1 2023 Q2Q % growth | -1.30 -39.78% | -1.09 | -0.21 | -18.77% |
| Q4 2022 Q2Q % growth | -1.01 -60.32% | -1.08 | 0.07 | 6.47% |
| Q3 2022 Q2Q % growth | -0.96 -62.71% | -0.91 | -0.05 | -5.91% |
| Q2 2022 Q2Q % growth | -0.90 -21.62% | -0.87 | -0.03 | -3.98% |
| Q1 2022 Q2Q % growth | -0.93 -27.40% | -0.70 | -0.23 | -33.75% |
| Q4 2021 Q2Q % growth | -0.63 24.10% | -0.62 | -0.01 | -1.13% |
| Q3 2021 Q2Q % growth | -0.59 -13.46% | -0.62 | 0.03 | 5.39% |
| Q2 2021 Q2Q % growth | -0.74 -10.45% | -0.74 | 0.00 | 0.10% |
| Q1 2021 Q2Q % growth | -0.73 -15.87% | -0.72 | -0.01 | -1.28% |
| Q4 2020 Q2Q % growth | -0.83 -232.00% | -0.48 | -0.35 | -72.22% |
| Q3 2020 Q2Q % growth | -0.52 1.89% | -0.53 | 0.01 | 1.49% |
| Q2 2020 Q2Q % growth | -0.67 52.14% | -0.49 | -0.18 | -38.08% |
| Q1 2020 Q2Q % growth | -0.63 | 0.11 | -0.74 | -661.50% |
| Q4 2019 Q2Q % growth | -0.25 | -0.53 | 0.28 | 53.23% |
| Q3 2019 Q2Q % growth | -0.53 | -0.59 | 0.06 | 10.02% |
| Q2 2019 Q2Q % growth | -1.40 | -0.46 | -0.94 | -201.66% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2024 Q2Q % growth | 3.708M -30.44% | 5.541M | -1.833M | -33.08% |
| Q3 2024 Q2Q % growth | 2.676M -50.00% | 6.975M | -4.299M | -61.63% |
| Q2 2024 Q2Q % growth | 9.361M -17.86% | 6.289M | 3.072M | 48.85% |
| Q1 2024 Q2Q % growth | 19.53M 298.90% | 6.15M | 13.38M | 217.56% |
| Q4 2023 Q2Q % growth | 5.331M 67.12% | 7.278M | -1.947M | -26.75% |
| Q3 2023 Q2Q % growth | 5.352M 76.05% | 13.35M | -7.998M | -59.91% |
| Q2 2023 Q2Q % growth | 11.397M 160.21% | 4.676M | 6.721M | 143.73% |
| Q1 2023 Q2Q % growth | 4.896M 26.84% | 3.959M | 937K | 23.67% |
| Q4 2022 Q2Q % growth | 3.19M -15.38% | 3.964M | -774K | -19.53% |
| Q3 2022 Q2Q % growth | 3.04M -29.79% | 5.576M | -2.536M | -45.48% |
| Q2 2022 Q2Q % growth | 4.38M 144.69% | 3.787M | 593K | 15.66% |
| Q1 2022 Q2Q % growth | 3.86M 113.26% | 4.499M | -639K | -14.20% |
| Q4 2021 Q2Q % growth | 3.77M -2.08% | 5.417M | -1.647M | -30.40% |
| Q3 2021 Q2Q % growth | 4.33M 12.76% | 4.521M | -191K | -4.22% |
| Q2 2021 Q2Q % growth | 1.79M 14.01% | 2.354M | -564K | -23.96% |
| Q1 2021 Q2Q % growth | 1.81M 60.18% | 1.844M | -34K | -1.84% |
| Q4 2020 Q2Q % growth | 3.85M -27.08% | 4.071M | -221K | -5.43% |
| Q3 2020 Q2Q % growth | 3.84M 529.51% | 3.177M | 663K | 20.87% |
| Q2 2020 Q2Q % growth | 1.57M 3.29% | 2.922M | -1.352M | -46.27% |
| Q1 2020 Q2Q % growth | 1.13M -82.29% | 10.561M | -9.431M | -89.30% |
| Q4 2019 Q2Q % growth | 5.28M | 1.887M | 3.393M | 179.81% |
| Q3 2019 Q2Q % growth | 610K | 1.346M | -736K | -54.68% |
| Q2 2019 Q2Q % growth | 1.52M | 1.055M | 465K | 44.08% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.94% | -0.14% | -0.89% | -0.36% |
| Revenue | 8.41% | 25.96% | 2.14% | 1.79% |